Sinus Therapeutic Drugs Market Outlook and Key Findings
The global sinus therapeutics drugs market is expected to witness a CAGR of over 4% between 2022 and 2032
North America and Europe collectively account for more than 50% of market share and this scenario is expected to persist in the forecast period as well.
Asia-Pacific is expected to grow at the fastest pace by 2032
Oral route of administration remains the preferred course of treatment.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Market Snapshot
Majority of sinus infections are reported to be caused by common cold and viral infections. These infections are classified as chronic and acute based on severity.
The chronic ones are those lasting for more than 3 months. Acute sinusitis get cured within 30 days.
At preliminary stage, sinus infections get diagnosed by physically inspecting characteristics of nasal mucosa, nasal septum’s structure, and presence of polyps.
The commonly prescribed sinus therapeutic drugs include painkillers, corticosteroids, sulfonamides, antibiotics, and antihistamines.
The antibiotics used for treating bacterial infections herein include cephalospotin’s, penicillin, and macrolides.
Prednisone, triamcinolone, fluticasone, and mometastone are amongst the corticosteroids used to treat sinus infections. Sulfa drugs are inclusive of trimethoprim and sulfamethoxazole.
Antibiotics are expected to witness exponentiation in the forecast period. This could be attributed to diagnostic technologies being developed post introducing rapid microbial tests.
Besides, market players are looking for expansion in the markets of Asia-Pacific like Indonesia, Philippines, China, and India. This trend is expected to boost the market during the forecast period.
The other treatment options include bacterial lysates, capsaicin, anti-IL5, anti-IgE, and antifungals
Innovations & Regulatory Approvals to be a Key Growth Factor
The sinus therapeutic drugs market players are treading the innovative path followed by approvals to table their superiority. These measures are bound to give impetus to the market during the forecast period.
For instance –
In Aug 2020, Xolair (omalizumab) from Novartis obtained approval from the European Commission in the form of an add-on therapy along with corticosteroids for treating chronic rhinosinusitis with the nasal polyps.
In Aug 2020, Satsuma Pharmaceuticals, Inc. announced initiation on the part of enrolment of patients in ASCEND trial – a multi-centre, 12-month, open-label study for evaluating tolerability and safety of STS101 (dihydroergotamine (DHE) nasal powder) in the form of acute treatment with respect to migraine.
In Aug 2020, Bryn Pharma reported to have raised US$ 11 Mn to enable advancement in Bi-Dose Epinephrine nasal spray to cure Anaphylaxis
In May 2020, Ondine Biomedical Inc. announced reception of CE mark with respect to its broad-spectrum non-antibiotic nasal decolonization therapy
In Jan 2020, Valtoco (diazepam nasal spray) was approved by the US FDA for treating cluster seizures. This type of medicine is generally referred to as “rescue therapy”
In Jan 2020, Lyra Therapeutics, Inc. announced that the US FDA had cleared its IND (Investigational New Drug) application regarding LYR-210 for treating CRS (chronic rhinosinusitis)
In Jan 2020, Lannett Company, Inc. announced approval by the US FDA to market “Numbrino”, one of the topical solutions for mucus membranes in nasal cavities.
Find your sweet spots for generating winning opportunities in this market.
Covid-19 Impact
The ongoing pandemic has compelled the sinus therapeutic drugs market players to speed up the production of drugs to address it, as it is a known fact that disorders in respiratory track can increase the risk of contraction.
For instance –
In Aug 2020, Atossa Therapeutics obtained approval from the US FDA for starting with AT-301 nasal spray’s clinical study. This nasal spray is being developed to combat Covid-19.
In Jul 2020, CEBINA GmBh announced positive results regarding Covid-19 drug repurposing project by identifying commonly used drugs that have been approved before against SARS-CoV-2 infection in the in-vitro assays. Azelastine is one such nasal spray.
Since the last few months, Aviptaadil Covid-19 therapeutic has been treating critical Covid-19.
Traditionally, the US and Western European countries have remained the most lucrative markets for sinus therapeutic drug manufacturers. The scenario is likely to witness significant change during the forecast period, as many countries in Asia Pacific are offering lucrative opportunities.
The Asia Pacific sinus therapeutics drugs market is likely to grow at the fastest pace in the forecast period, as the players are expanding in this region, and some of them are also reported to shift their base over here.
Moreover, many countries in Asia Pacific have world’s worst air quality, and respiratory disorders have witnessed a rapid spike, with rise in industrialization.
Sinus Therapeutic Drugs Market Players
The market players are launching new products to stand out as differentiators. This strategy is being emphasized on, and has kept the users guessing, regarding novelty.
For instance –
Recently, Janssen submitted Esketamine Nasal Spray novel drug application to the US FDA to restore connections between neural cells in those suffering from depression.
In Feb 2019, Fresenius Kabi introduced Methocarbamol injection to be available all across the US to address musculoskeletal pain resulting out of respiratory disorders.
In Jan 2019, Dr. Reddy’s Laboratories Ltd., along with Promius Pharma LLC announced approval of TOSYMRA to treat acute migraine.
The major players in the sinus therapeutic drug market include:
Sun Pharmaceutical Industries, Inc.
Reddy’s Laboratories, Inc.
Novartis AG
Tea Pharmaceutical Industries Ltd.
Pfizer Inc.
Fresenius Kabi USA
Janssen Pharmaceuticals, Inc.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Sinus Therapeutic Drugs Market: The Way Forward
The global sinus therapeutic drugs market is expected to witness a substantial CAGR of over 4% between 2022 and 2032. The onslaught of Covid-19 has resulted in increase in production of these drugs as it is directly related to disorders in the nasal tract.
The market players, though vying for innovation, should also think more from the inorganic growth perspective. As such, they should be looking forward to go for mergers, acquisitions, partnerships, joint ventures to be able to reach out to a broader audience.
Key Segment
Route of Administration
Oral
Topical
Injectable
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Disease Type
Acute Sinusitis
Sub-acute Sinusitis
Chronic Sinusitis
Geography
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa
Frequently Asked Questions
What is the Growth Outlook for Sinus Therapeutic Drugs Market?
The sinus therapeutic drugs market is likely to secure a CAGR of 4% through 2032.
By 2032, how much can the Sinus Therapeutic Drugs Market Grow?
The sinus therapeutic drugs market size is estimated to cross US$ 6.35 Bn by 2032.
What is the Current Valuation of the Sinus Therapeutic Drugs Market?
The sinus therapeutic drugs market is likely to record a value of US$ 4.29 Bn in 2022.
Which Region is likely to Lead the Sinus Therapeutic Drugs Market?
US is likely to lead the sinus therapeutic drugs market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Drug Development Trends
4. Key Success Factors
4.1. Adoption Analysis of Sinus Therapeutic Drugs
4.2. Regulatory Scenario
4.3. Reimbursement Scenario
4.4. Pipeline Analysis
4.5. Key Promotional Strategies, By Manufacturers
5. Sinus Therapeutic Drug Market Demand (Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
5.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
5.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.1.1. Global GDP Growth Outlook
6.1.2. Per Capita Healthcare Expenditure Outlook
6.2. Forecast Factors - Relevance & Impact
6.2.1. Growing Prevalence of Severe Allergic Asthma
6.2.2. Cost of Sinus Therapeutic Drug
6.2.3. Consolidation of Healthcare Industry
6.2.4. Increase in Patient Pool
6.3. Value Chain
6.4. Market Dynamics
6.4.1. Drivers
6.4.2. Restraints
6.4.3. Opportunity Analysis
6.5. COVID19 Crisis Analysis
6.5.1. Current COVID19 Statistics and Probable Future Impact
6.5.2. Current GDP Projection and Probable Impact
6.5.3. Current Economic Projection as compared to 2008 Economic analysis
6.5.4. COVID19 and Impact Analysis
6.5.4.1. Revenue By Drug Class
6.5.4.2. Revenue By Disease Type
6.5.4.3. Revenue By Route of Administration
6.5.4.4. Revenue By Distribution Channel
6.5.4.5. Revenue By Country
6.5.5. 2020 Market Scenario
6.5.6. Quarter by Quarter Forecast
6.5.7. Projected recovery Quarter
6.5.8. Recovery Scenario – Short term, Midterm and Long Term Impact
7. Global Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030, by Drug Class
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) By Drug Class, 2015-2019
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2020-2030
7.3.1. Аntіhіѕtаmіnеѕ
7.3.2. Аnаlgеѕісѕ
7.3.3. Ѕulрhоnаmіdеѕ
7.3.4. Соrtісоѕtеrоіdѕ
7.3.5. Аntіbіоtісѕ
7.3.6. NSAID’s
7.3.7. Оthеr Drug Сlаѕѕеѕ
7.4. Market Attractiveness Analysis By Drug Class
8. Global Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030, by Disease Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) By Disease Type, 2015-2019
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Type, 2020-2030
8.3.1. Асutе Sіnuѕіtіѕ
8.3.2. Ѕub-асutе Sіnuѕіtіѕ
8.3.3. Сhrоnіс Sіnuѕіtіѕ
8.4. Market Attractiveness Analysis By Disease Type
9. Global Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030, by Route of Administration
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2015-2019
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2020-2030
9.3.1. Oral
9.3.2. Topical
9.3.3. Injectable
9.4. Market Attractiveness Analysis By Route of Administration
10. Global Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030, by Distribution Channel
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2015-2019
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2020-2030
10.3.1. Ноѕріtаl Рhаrmасіеѕ
10.3.2. Rеtаіl Рhаrmасіе
10.3.3. Оnlіnе Рhаrmасіеѕ
10.4. Market Attractiveness Analysis By Distribution Channel
11. Global Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 - 2018
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Drug Class
12.3.3. By Disease Type
12.3.4. By Route of Administration
12.3.5. By Distribution Channel
12.4. Market Attractiveness Analysis
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis
13. Latin America Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 - 2018
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Drug Class
13.3.3. By Disease Type
13.3.4. By Route of Administration
13.3.5. By Distribution Channel
13.4. Market Attractiveness Analysis
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. Europe Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Drug Class
14.3.3. By Disease Type
14.3.4. By Route of Administration
14.3.5. By Distribution Channel
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. South Asia Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Drug Class
15.3.3. By Disease Type
15.3.4. By Route of Administration
15.3.5. By Distribution Channel
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. East Asia Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Drug Class
16.3.3. By Disease Type
16.3.4. By Route of Administration
16.3.5. By Distribution Channel
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. Oceania Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Drug Class
17.3.3. By Disease Type
17.3.4. By Route of Administration
17.3.5. By Distribution Channel
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. Middle East and Africa Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. Rest of Middle East and Africa
18.3.2. By Drug Class
18.3.3. By Disease Type
18.3.4. By Route of Administration
18.3.5. By Distribution Channel
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Key and Emerging Countries Sinus Therapeutic Drug Market Analysis 2015-2019 and Forecast 2020-2030
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. U.S. Sinus Therapeutic Drug Market Analysis
19.2.1. By Drug Class
19.2.2. By Disease Type
19.2.3. By Route of Administration
19.2.4. By Distribution Channel
19.3. Canada Sinus Therapeutic Drug Market Analysis
19.3.1. By Drug Class
19.3.2. By Disease Type
19.3.3. By Route of Administration
19.3.4. By Distribution Channel
19.4. Mexico Sinus Therapeutic Drug Market Analysis
19.4.1. By Drug Class
19.4.2. By Disease Type
19.4.3. By Route of Administration
19.4.4. By Distribution Channel
19.5. Brazil Sinus Therapeutic Drug Market Analysis
19.5.1. By Drug Class
19.5.2. By Disease Type
19.5.3. By Route of Administration
19.5.4. By Distribution Channel
19.6. U.K. Sinus Therapeutic Drug Market Analysis
19.6.1. By Drug Class
19.6.2. By Disease Type
19.6.3. By Route of Administration
19.6.4. By Distribution Channel
19.7. Germany Sinus Therapeutic Drug Market Analysis
19.7.1. By Drug Class
19.7.2. By Disease Type
19.7.3. By Route of Administration
19.7.4. By Distribution Channel
19.8. France Sinus Therapeutic Drug Market Analysis
19.8.1. By Drug Class
19.8.2. By Disease Type
19.8.3. By Route of Administration
19.8.4. By Distribution Channel
19.9. Italy Sinus Therapeutic Drug Market Analysis
19.9.1. By Drug Class
19.9.2. By Disease Type
19.9.3. By Route of Administration
19.9.4. By Distribution Channel
19.10. Spain Sinus Therapeutic Drug Market Analysis
19.10.1. By Drug Class
19.10.2. By Disease Type
19.10.3. By Route of Administration
19.10.4. By Distribution Channel
19.11. BENELUX Sinus Therapeutic Drug Market Analysis
19.11.1. By Drug Class
19.11.2. By Disease Type
19.11.3. By Route of Administration
19.11.4. By Distribution Channel
19.12. Russia Sinus Therapeutic Drug Market Analysis
19.12.1. By Drug Class
19.12.2. By Disease Type
19.12.3. By Route of Administration
19.12.4. By Distribution Channel
19.13. China Sinus Therapeutic Drug Market Analysis
19.13.1. By Drug Class
19.13.2. By Disease Type
19.13.3. By Route of Administration
19.13.4. By Distribution Channel
19.14. Japan Sinus Therapeutic Drug Market Analysis
19.14.1. By Drug Class
19.14.2. By Disease Type
19.14.3. By Route of Administration
19.14.4. By Distribution Channel
19.15. South Korea Sinus Therapeutic Drug Market Analysis
19.15.1. By Drug Class
19.15.2. By Disease Type
19.15.3. By Route of Administration
19.15.4. By Distribution Channel
19.16. India Sinus Therapeutic Drug Market Analysis
19.16.1. By Drug Class
19.16.2. By Disease Type
19.16.3. By Route of Administration
19.16.4. By Distribution Channel
19.17. Australia Sinus Therapeutic Drug Market Analysis
19.17.1. By Drug Class
19.17.2. By Disease Type
19.17.3. By Route of Administration
19.17.4. By Distribution Channel
19.18. New Zealand Sinus Therapeutic Drug Market Analysis
19.18.1. By Drug Class
19.18.2. By Disease Type
19.18.3. By Route of Administration
19.18.4. By Distribution Channel
19.19. GCC Countries Sinus Therapeutic Drug Market Analysis
19.19.1. By Drug Class
19.19.2. By Disease Type
19.19.3. By Route of Administration
19.19.4. By Distribution Channel
19.20. Turkey Sinus Therapeutic Drug Market Analysis
19.20.1. By Drug Class
19.20.2. By Disease Type
19.20.3. By Route of Administration
19.20.4. By Distribution Channel
19.21. South Africa Sinus Therapeutic Drug Market Analysis
19.21.1. By Drug Class
19.21.2. By Disease Type
19.21.3. By Route of Administration
19.21.4. By Distribution Channel
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Concentration
20.3. Market Share Analysis of Top Players
20.4. Market Presence Analysis
20.4.1. By Regional footprint of Players
20.4.2. Product foot print by Players
20.4.3. Channel Foot Print by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. AstraZeneca
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Profitability by Market Segments (Product/Channel/Region)
21.3.1.4. Sales Footprint
21.3.1.5. Strategy Overview
21.3.1.5.1. Marketing Strategy
21.3.1.5.2. Product Strategy
21.3.1.5.3. Channel Strategy
21.3.2. Bausch Health
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Profitability by Market Segments (Product/Channel/Region)
21.3.2.4. Sales Footprint
21.3.2.5. Strategy Overview
21.3.2.5.1. Marketing Strategy
21.3.2.5.2. Product Strategy
21.3.2.5.3. Channel Strategy
21.3.3. Nоvаrtіѕ АG
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Profitability by Market Segments (Product/Channel/Region)
21.3.3.4. Sales Footprint
21.3.3.5. Strategy Overview
21.3.3.5.1. Marketing Strategy
21.3.3.5.2. Product Strategy
21.3.3.5.3. Channel Strategy
21.3.4. Ѕun Рhаrmасеutісаl Іnduѕtrіеѕ, Іnс
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Profitability by Market Segments (Product/Channel/Region)
21.3.4.4. Sales Footprint
21.3.4.5. Strategy Overview
21.3.4.5.1. Marketing Strategy
21.3.4.5.2. Product Strategy
21.3.4.5.3. Channel Strategy
21.3.5. Rеddу'ѕ Lаbоrаtоrіеѕ, Іnс.
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Profitability by Market Segments (Product/Channel/Region)
21.3.5.4. Sales Footprint
21.3.5.5. Strategy Overview
21.3.5.5.1. Marketing Strategy
21.3.5.5.2. Product Strategy
21.3.5.5.3. Channel Strategy
21.3.6. Теа Рhаrmасеutісаl Іnduѕtrіеѕ Ltd.
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Profitability by Market Segments (Product/Channel/Region)
21.3.6.4. Sales Footprint
21.3.6.5. Strategy Overview
21.3.6.5.1. Marketing Strategy
21.3.6.5.2. Product Strategy
21.3.6.5.3. Channel Strategy
21.3.7. Frеѕеnіuѕ Каbі UЅА
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Profitability by Market Segments (Product/Channel/Region)
21.3.7.4. Sales Footprint
21.3.7.5. Strategy Overview
21.3.7.5.1. Marketing Strategy
21.3.7.5.2. Product Strategy
21.3.7.5.3. Channel Strategy
21.3.8. Јоhnѕоn & Јоhnѕоn
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Profitability by Market Segments (Product/Channel/Region)
21.3.8.4. Sales Footprint
21.3.8.5. Strategy Overview
21.3.8.5.1. Marketing Strategy
21.3.8.5.2. Product Strategy
21.3.8.5.3. Channel Strategy
21.3.9. Рfіzеr Іnс
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Profitability by Market Segments (Product/Channel/Region)
21.3.9.4. Sales Footprint
21.3.9.5. Strategy Overview
21.3.9.5.1. Marketing Strategy
21.3.9.5.2. Product Strategy
21.3.9.5.3. Channel Strategy
21.3.10. Јаnѕѕеn Рhаrmасеutісаlѕ, Іnс.
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Profitability by Market Segments (Product/Channel/Region)
21.3.10.4. Sales Footprint
21.3.10.5. Strategy Overview
21.3.10.5.1. Marketing Strategy
21.3.10.5.2. Product Strategy
21.3.10.5.3. Channel Strategy
21.3.11. GlaxoSmithKline plc
21.3.11.1. Overview
21.3.11.2. Product Portfolio
21.3.11.3. Profitability by Market Segments (Product/Channel/Region)
21.3.11.4. Sales Footprint
21.3.11.5. Strategy Overview
21.3.11.5.1. Marketing Strategy
21.3.11.5.2. Product Strategy
21.3.11.5.3. Channel Strategy
22. Assumptions and Acronyms Used23. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Drug Class
Table 02: Global Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Disease Type
Table 03: Global Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Route of Administration
Table 04: Global Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Distribution Channel
Table 05: Global Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Region
Table 06: North America Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 07: North America Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class
Table 08: North America Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Disease Type
Table 09: North America Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Route of Administration
Table 10: North America Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel
Table 11: Latin America Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 12: Latin America Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class
Table 13: Latin America Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Disease Type
Table 14: Latin America Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Route of Administration
Table 15: Latin America Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel
Table 16: Europe Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 17: Europe Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class
Table 18: Europe Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Disease Type
Table 19: Europe Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Route of Administration
Table 20: Europe Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel
Table 21: South Asia Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 22: South Asia Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class
Table 23: South Asia Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Disease Type
Table 24: South Asia Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Route of Administration
Table 25: South Asia Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel
Table 26: East Asia Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 27: East Asia Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class
Table 28: East Asia Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Disease Type
Table 29: East Asia Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Route of Administration
Table 30: East Asia Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel
Table 31: Oceania Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 32: Oceania Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class
Table 33: Oceania Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Disease Type
Table 34: Oceania Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Route of Administration
Table 35: Oceania Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel
Table 36: MEA Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country
Table 37: MEA Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class
Table 38: MEA Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Disease Type
Table 39: MEA Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Route of Administration
Table 40: MEA Sinus Therapeutic Drug Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Global Sinus Therapeutic Drug Market Value Share, By Drug Class, 2019 (A)
Figure 02: Global Sinus Therapeutic Drug Market Value Share, By Disease Type, 2019 (A)
Figure 03: Global Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2019 (A)
Figure 04: Global Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2019 (A)
Figure 05: Global Sinus Therapeutic Drug Market Value Analysis 2015-2019 & 2020-2030
Figure 06: Global Sinus Therapeutic Drug Market Y-O-Y Growth Analysis By Region
Figure 07: Global Sinus Therapeutic Drug Market Value Analysis and Forecast, 2020–2030 (US$ Mn)
Figure 08: Global Sinus Therapeutic Drug Market Absolute $ Opportunity (US$ Mn), 2015–2019
Figure 09: Global Sinus Therapeutic Drug Market Absolute $ Opportunity (US$ Mn), 2020–2030
Figure 10: Global Sinus Therapeutic Drug Market Share Analysis (%) By Drug Class, 2020 & 2030
Figure 11: Global Sinus Therapeutic Drug Market Y-o-Y Growth (%) By Drug Class, 2020–2030
Figure 12: Global Sinus Therapeutic Drug Market Attractiveness Analysis By Drug Class, 2020–2030
Figure 13: Global Sinus Therapeutic Drug Market Share Analysis (%) By Disease Type, 2020 & 2030
Figure 14: Global Sinus Therapeutic Drug Market Y-o-Y Growth (%) By Disease Type, 2020–2030
Figure 15: Global Sinus Therapeutic Drug Market Attractiveness Analysis By Disease Type, 2020–2030
Figure 16: Global Sinus Therapeutic Drug Market Share Analysis (%) By Route of Administration, 2020 & 2030
Figure 17: Global Sinus Therapeutic Drug Market Y-o-Y Growth (%) By Route of Administration, 2020–2030
Figure 18: Global Sinus Therapeutic Drug Market Attractiveness Analysis By Route of Administration, 2020–2030
Figure 19: Global Sinus Therapeutic Drug Market Share Analysis (%) By Distribution Channel, 2020 & 2030
Figure 20: Global Sinus Therapeutic Drug Market Y-o-Y Growth (%) By Distribution Channel, 2020–2030
Figure 21: Global Sinus Therapeutic Drug Market Attractiveness Analysis By Distribution Channel, 2020–2030
Figure 22: Global Sinus Therapeutic Drug Market Share Analysis (%) By Region, 2020 & 2030
Figure 23: Global Sinus Therapeutic Drug Market Y-o-Y Growth (%) By Region, 2020–2030
Figure 24: Global Sinus Therapeutic Drug Market Attractiveness Analysis By Region, 2020–2030
Figure 25: North America Sinus Therapeutic Drug Market Value Analysis, 2015–2019
Figure 26: North America Sinus Therapeutic Drug Market Forecast & Y-o-Y growth, 2020–2030
Figure 27: North America Sinus Therapeutic Drug Market Attractiveness Analysis By Country, 2020-2030
Figure 28: North America Sinus Therapeutic Drug Market Attractiveness Analysis By Drug Class, 2020-2030
Figure 29: North America Sinus Therapeutic Drug Market Attractiveness Analysis By Disease Type, 2020-2030
Figure 30: North America Sinus Therapeutic Drug Market Attractiveness Analysis By Route of Administration, 2020-2030
Figure 31: North America Sinus Therapeutic Drug Market Attractiveness Analysis By Distribution Channel, 2020-2030
Figure 32: Latin America Sinus Therapeutic Drug Market Value Analysis, 2015–2019
Figure 33: Latin America Sinus Therapeutic Drug Market Forecast & Y-o-Y growth, 2020–2030
Figure 34: Latin America Sinus Therapeutic Drug Market Attractiveness Analysis By Country, 2020-2030
Figure 35: Latin America Sinus Therapeutic Drug Market Attractiveness Analysis By Drug Class, 2020-2030
Figure 36: Latin America Sinus Therapeutic Drug Market Attractiveness Analysis By Disease Type, 2020-2030
Figure 37: Latin America Sinus Therapeutic Drug Market Attractiveness Analysis By Route of Administration, 2020-2030
Figure 38: Latin America Sinus Therapeutic Drug Market Attractiveness Analysis By Distribution Channel, 2020-2030
Figure 39: Europe Sinus Therapeutic Drug Market Value Analysis, 2015–2019
Figure 40: Europe Sinus Therapeutic Drug Market Forecast & Y-o-Y growth, 2020–2030
Figure 41: Europe Sinus Therapeutic Drug Market Attractiveness Analysis By Country, 2020-2030
Figure 42: Europe Sinus Therapeutic Drug Market Attractiveness Analysis By Drug Class, 2020-2030
Figure 43: Europe Sinus Therapeutic Drug Market Attractiveness Analysis By Disease Type, 2020-2030
Figure 44: Europe Sinus Therapeutic Drug Market Attractiveness Analysis By Route of Administration, 2020-2030
Figure 45: Europe Sinus Therapeutic Drug Market Attractiveness Analysis By Distribution Channel, 2020-2030
Figure 46: South Asia Sinus Therapeutic Drug Market Value Analysis, 2015–2019
Figure 47: South Asia Sinus Therapeutic Drug Market Forecast & Y-o-Y growth, 2020–2030
Figure 48: South Asia Sinus Therapeutic Drug Market Attractiveness Analysis By Country, 2020-2030
Figure 49: South Asia Sinus Therapeutic Drug Market Attractiveness Analysis By Drug Class, 2020-2030
Figure 50: South Asia Sinus Therapeutic Drug Market Attractiveness Analysis By Disease Type, 2020-2030
Figure 51: South Asia Sinus Therapeutic Drug Market Attractiveness Analysis By Route of Administration, 2020-2030
Figure 52: South Asia Sinus Therapeutic Drug Market Attractiveness Analysis By Distribution Channel, 2020-2030
Figure 53: East Asia Sinus Therapeutic Drug Market Value Analysis, 2015–2019
Figure 54: East Asia Sinus Therapeutic Drug Market Forecast & Y-o-Y growth, 2020–2030
Figure 55: East Asia Sinus Therapeutic Drug Market Attractiveness Analysis By Country, 2020-2030
Figure 56: East Asia Sinus Therapeutic Drug Market Attractiveness Analysis By Drug Class, 2020-2030
Figure 57: East Asia Sinus Therapeutic Drug Market Attractiveness Analysis By Disease Type, 2020-2030
Figure 58: East Asia Sinus Therapeutic Drug Market Attractiveness Analysis By Route of Administration, 2020-2030
Figure 59: East Asia Sinus Therapeutic Drug Market Attractiveness Analysis By Distribution Channel, 2020-2030
Figure 60: Oceania Sinus Therapeutic Drug Market Value Analysis, 2015–2019
Figure 61: Oceania Sinus Therapeutic Drug Market Forecast & Y-o-Y growth, 2020–2030
Figure 62: Oceania Sinus Therapeutic Drug Market Attractiveness Analysis By Country, 2020-2030
Figure 63: Oceania Sinus Therapeutic Drug Market Attractiveness Analysis By Drug Class, 2020-2030
Figure 64: Oceania Sinus Therapeutic Drug Market Attractiveness Analysis By Disease Type, 2020-2030
Figure 65: Oceania Sinus Therapeutic Drug Market Attractiveness Analysis By Route of Administration, 2020-2030
Figure 66: Oceania Sinus Therapeutic Drug Market Attractiveness Analysis By Distribution Channel, 2020-2030
Figure 67: MEA Sinus Therapeutic Drug Market Value Analysis, 2015–2019
Figure 68: MEA Sinus Therapeutic Drug Market Forecast & Y-o-Y growth, 2020–2030
Figure 69: MEA Sinus Therapeutic Drug Market Attractiveness Analysis By Country, 2020-2030
Figure 70: MEA Sinus Therapeutic Drug Market Attractiveness Analysis By Drug Class, 2020-2030
Figure 71: MEA Sinus Therapeutic Drug Market Attractiveness Analysis By Disease Type, 2020-2030
Figure 72: MEA Sinus Therapeutic Drug Market Attractiveness Analysis By Route of Administration, 2020-2030
Figure 73: MEA Sinus Therapeutic Drug Market Attractiveness Analysis By Distribution Channel, 2020-2030
Figure 74: US Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)
Figure 75: US Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)
Figure 76: US Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)
Figure 77: US Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)
Figure 78: Canada Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)
Figure 79: Canada Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)
Figure 80: Canada Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)
Figure 81: Canada Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)
Figure 82: Brazil Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)
Figure 83: Brazil Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)
Figure 84: Brazil Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)
Figure 85: Brazil Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)
Figure 86: Mexico Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)
Figure 87: Mexico Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)
Figure 88: Mexico Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)
Figure 89: Mexico Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)
Figure 90: Germany Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)
Figure 91: Germany Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)
Figure 92: Germany Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)
Figure 93: Germany Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)
Figure 94: Italy Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)
Figure 95: Italy Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)
Figure 96: Italy Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)
Figure 97: Italy Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)
Figure 98: France Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)
Figure 99: France Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)
Figure 100: France Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)
Figure 101: France Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)
Figure 102: U.K. Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)
Figure 103: U.K. Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)
Figure 104: U.K. Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)
Figure 105: U.K. Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)
Figure 106: Spain Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)
Figure 107: Spain Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)
Figure 108: Spain Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)
Figure 109: Spain Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)
Figure 110: BENELUX Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)
Figure 111: BENELUX Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)
Figure 112: BENELUX Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)
Figure 113: BENELUX Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)
Figure 114: Russia Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)
Figure 115: Russia Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)
Figure 116: Russia Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)
Figure 117: Russia Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)
Figure 118: China Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)
Figure 119: China Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)
Figure 120: China Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)
Figure 121: China Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)
Figure 122: Japan Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)
Figure 123: Japan Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)
Figure 124: Japan Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)
Figure 125: Japan Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)
Figure 126: South Korea Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)
Figure 127: South Korea Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)
Figure 128: South Korea Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)
Figure 129: South Korea Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)
Figure 130: India Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)
Figure 131: India Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)
Figure 132: India Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)
Figure 133: India Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)
Figure 134: Australia Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)
Figure 135: Australia Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)
Figure 136: Australia Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)
Figure 137: Australia Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)
Figure 138: New Zealand Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)
Figure 139: New Zealand Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)
Figure 140: New Zealand Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)
Figure 141: New Zealand Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)
Figure 142: GCC Countries Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)
Figure 143: GCC Countries Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)
Figure 144: GCC Countries Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)
Figure 145: GCC Countries Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)
Figure 146: South Africa Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)
Figure 147: South Africa Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)
Figure 148: South Africa Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)
Figure 149: South Africa Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)
Figure 150: Turkey Sinus Therapeutic Drug Market Value Share, By Drug Class, 2020 (E)
Figure 151: Turkey Sinus Therapeutic Drug Market Value Share, By Disease Type, 2020 (E)
Figure 152: Turkey Sinus Therapeutic Drug Market Value Share, By Route of Administration, 2020 (E)
Figure 153: Turkey Sinus Therapeutic Drug Market Value Share, By Distribution Channel, 2020 (E)
